Luoyang Third Peoples Hospital

Luoyang, Henan 471002

1 studies enrolling now · 3 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Atrial Fibrillation, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, High-risk Transient Ischemic Attack, Obesity, Prevention of Ischemic Stroke, Prevention of Stroke or Systemic Embolism

Studies at this site

• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early